Grifols SA raised €1.3 billion ($1.4 billion) in a private debt placement, as the Spanish drugmaker seeks to reassure investors about its ability to manage borrowings.
The notes were issued at 7.125% and are due in May 2030, with proceeds earmarked mostly to fully redeem notes due February next year and repay loans due in November, the company said in a regulatory filing late Wednesday. It also announced an 18-month extension of an existing revolving credit facility, to May 2027.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.